Consumer Health

Economic instability, characterised by very high inflation, continues to restrain retail volume sales at the end of the review period. The Turkish economy is taking longer than many other countries to recover from the economic effects of Coronavirus…

Uganda’s economy saw real GDP growth of 5% in 2023 and this provided a boost to sales of some consumer health products. Self-medication is driving growth in consumer health in Uganda as consumers are finding it easier and cheaper to purchase…

The picture is fairly positive in 2023, with constant value sales expected to rise slightly and inflationary pressure easing. However, rising prices are still an issue and the overall economy is expected to register a slowdown in growth.

Consumer health in 2023 is exhibiting solid current value growth as the impact of the COVID-19 pandemic diminishes. With the resurgence of seasonal ailments, categories such as cough, cold and allergy (hay fever) remedies and analgesics are…

Current value sales of consumer health in Vietnam continue to record strong growth in line with the rising trend of health and wellness in the country. Post-pandemic, the majority of Vietnamese consumers are taking greater care of their health, and…

While coughs, colds and the flu were less prevalent during the home seclusion of 2020, negatively impacting sales of cough and cold remedies in this year, they returned in full in the 2022/2023 winter season, with society fully reopened, boosting…

In mid-March 2021, Euromonitor International published revised Q1 forecasts for consumer health in the context of a slightly more positive macroeconomic outlook. The implications of this revision are expected to be muted for consumer health, as it is…

Expectations for the global consumer health industry have improved slightly for Q2 2021. Improved macroeconomic forecasts due to widening vaccination rates in markets such as the US will benefit consumer health, especially as consumers emerge from…

In mid-July 2020, Euromonitor published revised forecasts for Consumer Health in the wake of the Coronavirus pandemic. On the whole, Coronavirus (COVID-19) is expected to somewhat suppress global growth of Consumer Health in 2020, but the effects are…

In the upcoming years, consumers and businesses face an array of challenges, with income inequality, mass migration and rising uncertainty about another crisis being among the major ones. Nevertheless, within this lie untapped opportunities. This…

Cough, cold and allergy (hay fever) remedies are expected to perform better in 2023 than in the previous year, with positive value and volume growth. As life in Algeria returns to normal, and social contact increases, there is increased coughs, colds…

Retail sales of cough, cold and allergy (hay fever) remedies saw another year of healthy growth in constant value terms in 2023. With the resumption of pre-pandemic lifestyles, including a return to work, school and social activities, consumers…

Australia has been impacted by an extended season of colds and flu in 2023, with many Australians becoming ill. As the lockdowns and COVID-19 restrictions were lifted, people no longer followed social distancing, and fewer Australians have been…

Cough, cold and allergy (hay fever) remedies received a strong sales boost in 2022 due to consumers returning to working in the office more frequently again and kids returning to in-school classes. This led to consumers spending more time among other…

As COVID-19 restrictions lift and society returns to face-to-face interaction, the regular seasonal sicknesses —colds and flus—are making their own return to Azerbaijan. More social mingling means not just handshakes and hugs on the rise; sniffling…

Sales of cough, cold and allergy (hay fever) remedies are seeing strong growth in current value terms in 2023. This is partly due to inflation-driven price increases (also the consequence of supply shortages in some cases) and an increase in cough,…

Seasonal flus have returned, as people mix together once again , post pandemic, and cough, cold and allergy (hay fever remedies) are expected to register moderate current value growth, though constant value growth will be minimal, as rising costs hit…

Cough, cold and allergy (hay fever) continues to rebound following the declines during the COVID-19 pandemic and the slow recovery in its aftermath. Unit prices have been driven up by inflation resulting in double-digit current value growth in 2023,…

In 2023, cough, cold and allergy (hay fever) remedies is set to maintain dynamic current value growth in Brazil. In this year, the conclusion of the Public Health Emergency of International Concern (PHEIC) for COVID-19, as declared by the World…

Price sensitivity among Bulgarian consumers is a key factor influencing their purchasing decisions when it comes to cough, cold, and allergy (hay fever) remedies. As the minimum wage in Bulgaria is just under EUR400 in 2023, a significant portion of…